The role of progestogens in obstetrics practice

Abstract

Objective: in this paper reviews the evidence for safety and efficacy of use of any progestogens in each of these indications. Progestogens may be use for the prevention of preterm labour, but not only for therapy spontaneous abortion.

Keywords

progestogens / preterm labour

References

[1] Гуменюк Е. Г., Власова Е. А., Кармакова Т. Л. Акушерские и перинатальные исходы у женщин, получавших Дюфастон во время беременности // Гинекология. — 2008. — Т. 10, № 4. — С. 67–71.

[2] Молекулярные механизмы дидрогестерона (Дюфастон). Полногеномное исследование транскрипционных эффектов рецепторов прогестерона, андрогенов и эстрогенов / Торшин И. Ю., Громова О. А., Сухих Г. Т., Галицкая С. А., Юргель И. С. // Гинекологическая эндокринология. — 2010. — № 11. — С. 9–16.

[3] Состояние здоровья новорожденных, рожденных от матерей с угрозой прерывания беременности / Башмакова Н. В., Мелкозерова О. А., Винокурова Е. А., Пепеляева Н. А. // Проблемы репродукции. — 2004. — № 2. — С. 59–61.

[4] Шестакова И. Г. Реабилитация эндометрия после потери беременности // Гинекология. — 2009.— Т. 11, № 4. — С. 55–58.

[5] A new class of hormonally active steroids / Reerink E. H., Scholer H. F., Westerhof P. [et al.] // Nature. — 1960. — Vol. 186. — P. 168–169.

[6] Allopregnanolone concentrations and premenstrual syndrome / Monteleone P., Luisi S., Tonetti A. [et al.] // Eur. J. Endocrinol. — 2000. — Vol. 142. — P. 269–273.

[7] Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8 % gel and Utrogestan capsules, used for luteal support / Simunic V., Tomic V., Tomic J. [et al.] // Fertil. Steril. — 2007. — Vol. 87. — P. 83–87.

[8] Conversion of plasma progesterone to deoxycorticosterone/Winkel C. A., Milewich l., Parker C. R. [et al.] // J. Clin. Invest. — 1980. — Vol. 66. — P. 803–812.

[9] Direct inhibitory effect of progesterone on oxytocin — induced secretion of prostaglandin F2alfa / Bogacki M., Silvia W., Rekawiecki R., Kotwika J. // Biol. Reprod. — 2002. — Vol. 67. — P. 184–188.

[10] Druckmann R., Druckmann M. A. Progesterone and the immunology of pregnancy // J. Steroid. Biochem. Mol. Biol. — 2005. — Vol. 97. — P. 389–396.

[11] Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure / Bourgain C., Devroey P., Van Waesberghe L. [et al.] // Hum. Reprod. — 1990. — Vol. 5. — P. 537–543.

[12] Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis in pregnancy / Meng L. J., Reyes H., Palma J. [et al.] // J. Hepatol. — 1997. — Vol. 27. — P. 1029–1033.

[13] Guidelines for the management of spontaneous preterm labour / Di Renzo G. C., Roura L. C., Facchinetti F. [et al.] // J. Matern. Fetal Neonatal. Med. — 2011. — Vol. 24. — P. 659–667.

[14] O’Brein J. M. 17-hydroxyprogesterone caproate, progesterone, preterm birth prevention, and safety: who decides? // Am. J. Obstet. Gynecol. — 2011. — Vol. 204. — P. 16–17.

[15] Prevention of recurrent preterm delivery by 17-alpha- hydroxyprogesterone caproate / Meis P. J., Klebanoff M., Thom E. [et al.] // N. Eng. J. Med. — 2003. — Vol. 348. — P. 2379–2385.

[16] Progesterone — treated limphocytes of healthy pregnant women release a factor inhibiting cytotoxicity and prostaglandin synthesis / Szekeres-Bartho J., Kilar F., Falkay G. [et al.] // Am. J. Reprod. Immunol. — 1985. — Vol. 9. — P.15–19.

[17] Prostaglandins differentially modulate progesterone receptor-A and B expression in human myometrial cells / Madsen G., Zakar T., Ku C. Y. [et al.] // J. Clin. Endocrinol. Metabol. — 2004. — Vol. 89. — P. 1010–1015.

[18] Queisser-Luft A. Dydrogesterone use during pregnancy; overview of birth defects reported since 1977 // Early Hum. Dev. — 2009. — Vol. 85. — P. 375–377.

[19] Schindler A. E. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium // Maturitas. — 2009. — Vol. 65. — P. 3–11.

[20] Studies maternal and fetal 11-DOC in normal and toxemic pregnancy / Den K., Tomita M., Miyake Y. [et al.] // Endocrinol. Jap. — 1980. — Vol. 27. — P. 703–708.

[21] The changing role of progesterone in preterm labour / Di Renzo G. C., Rosati A., Mattei A. [et al.] // BJOG. — 2005. — Vol. 112. — P. 57–60.

[22] The role of progesterone in maternal and fetal medicine / Di Renzo G. C., Giardina I., Clerici G. [et al.] // Gynecol. Endocrinol. — 2012. — Vol. 28. — P. 925–932.

[23] Vaginal progesterone is associated with decrease in risk early preterm labour and improved neonatal outcome in women with a short cervix / De Franco E. A., O’Brein J. M., Adair C. D. [et al.] // Ultrasound Obstet. Gynecol. — 2007. — Vol. 30. — P. 697–705.

RIGHTS & PERMISSIONS

Repina M.A., Bobrov S.A.